EDGAR Filing Documents for 0001485003-17-000142

Form 8-K - Current report:

SEC Accession No. 0001485003-17-000142

Filing Date

2017-11-16

Accepted

2017-11-16 09:05:34

Documents

Period of Report

2017-11-15

Items

Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	ebio-form8xkdelayinform10x.htm	8-K	32006
2	EXHIBIT 99.1	exhibit991.htm	EX-99.1	8945
	Complete submission text file	0001485003-17-000142.txt		42058

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 171206810
SIC: 2834 Pharmaceutical Preparations